Sai Parenterals Limited

Quant Mutual Fund, which previously held a 3.81 percent stake in Sai Parenterals Limited, is no longer listed among the company's disclosed shareholders, indicating either a complete exit or a reduction of its holding to below the 1 percent reporting requirement.

A diversified pharmaceutical formulations company, Sai Parenteral's specializes in the research, development, and manufacturing of injectable and parenteral drugs for multiple therapeutic areas. Incorporated in 2001, the company maintains expertise in complex formulation technologies and operates integrated manufacturing facilities. It serves both domestic and international markets, with a focus on quality compliance and advanced pharmaceutical solutions across its product portfolio.

Built a quantitative, data-driven investment philosophy in an industry dominated by discretionary stock pickers. Manages over Rs 1.2 lakh crore. Founded by Sanjeev Sharma, Quant MF uses VLRT (Valuation, Liquidity, Risk, and Time) framework to run high-turnover, tactically active portfolios. Grew from obscurity to one of India's top-15 AMCs in under five years, attracting both retail capital and scrutiny for its aggressive churn.